How should Auvi‑Q (epinephrine) be injected subcutaneously in the outer thigh?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Inject Auvi-Q into the Outer Thigh

Remove the outer case of Auvi-Q (which automatically activates voice instructions), pull off the RED safety guard, place the black end against the outer thigh, press firmly and hold for 5 seconds 1.

Step-by-Step Administration

The FDA-approved technique for Auvi-Q is straightforward and differs from other epinephrine auto-injectors:

  1. Remove the outer case - This action automatically triggers the device's voice instruction system 1

  2. Pull off the RED safety guard - This is the critical safety step before injection 1

  3. Position the black end against the anterolateral aspect of the outer thigh - The injection can be administered through clothing if necessary 2

  4. Press firmly and hold for 5 seconds - This is shorter than the 10-second hold required for EpiPen 1

  5. The device will provide a 2-second countdown, then voice instructions will confirm injection completion 2

Route of Administration

Auvi-Q is FDA-approved for both intramuscular OR subcutaneous injection 2. While intramuscular injection into the anterolateral thigh produces higher and more rapid peak plasma levels compared to subcutaneous or arm injections 3, the clinical significance of this difference remains unclear 3. The device is specifically designed to deliver epinephrine through either route when administered to the outer thigh.

Critical Safety Considerations

For young children and infants: Caregivers must hold the child's leg firmly in place and limit movement both prior to and during injection, as uncooperative children may kick or move 2. This is essential to prevent inadvertent needle injuries.

Post-injection indicators: After use, Auvi-Q's black base locks onto the device housing and lights blink red, confirming the injection was administered 2. The needle automatically retracts and will not be visible after injection 2.

Repeat dosing: If symptoms persist or recur after 5 minutes, a second injection may be necessary 1. However, more than two sequential doses should only be administered under direct medical supervision 2.

Common Pitfalls to Avoid

  • Do NOT inject into digits, hands, feet, or buttocks - these sites risk serious vasoconstriction complications 2
  • Do NOT inject intravenously - this route has been associated with anaphylaxis fatalities 3
  • Do NOT delay for clothing removal - inject through clothing if necessary 2
  • Do NOT assume you'll feel the injection - patients may not perceive the needle penetration 2

Device-Specific Advantages

Auvi-Q demonstrates superior usability compared to other auto-injectors, with 85.4% of untrained adults completing all injection tasks correctly versus 19.8% with EpiPen Jr 4. The device's voice instructions, visual prompts, and automatic needle retraction system significantly reduce user error 4. Bioavailability studies confirm Auvi-Q delivers equivalent epinephrine exposure to EpiPen 5.

Always seek immediate emergency medical care after administration, even if symptoms improve 2. The device contains a single dose only and cannot be reused 2.

References

Guideline

the diagnosis and management of anaphylaxis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2005

Research

Usability and preference of epinephrine auto-injectors: Auvi-Q and EpiPen Jr.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2019

Research

Bioavailability of epinephrine from Auvi-Q compared with EpiPen.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.